What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria
- PMID: 16985803
- PMCID: PMC1477555
What's New in Prostate Cancer, Benign Prostatic Hyperplasia, and Minimally Invasive Surgery?: Highlights from the XIXth Congress of the European Association of Urology, March 23-27, 2004, Vienna, Austria
Figures
Similar articles
-
New findings in benign prostatic hyperplasia and incontinence: highlights from the 26th annual congress of the European association of urology, march 18-22, 2011, vienna, austria.Rev Urol. 2011;13(2):112-7. Rev Urol. 2011. PMID: 21935344 Free PMC article. No abstract available.
-
New Findings in Prostate Cancer, Benign Prostatic Hyperplasia, and Sexual Dysfunction: Highlights from the XVIII Congress of the European Association of Urology, March 12-15, 2003, Madrid, Spain.Rev Urol. 2004 Winter;6(1):19-28. Rev Urol. 2004. PMID: 16985567 Free PMC article. No abstract available.
-
New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria.Can J Urol. 2011 Apr;18(2):5601-7. Can J Urol. 2011. PMID: 21504647
-
Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.Eur Urol Focus. 2020 Sep 15;6(5):1032-1048. doi: 10.1016/j.euf.2020.05.007. Epub 2020 May 31. Eur Urol Focus. 2020. PMID: 32553544 Free PMC article. Review.
-
What's truly minimally invasive in benign prostatic hyperplasia surgery?Curr Opin Urol. 2014 Jan;24(1):36-41. doi: 10.1097/MOU.0000000000000006. Curr Opin Urol. 2014. PMID: 24247171 Review.
References
-
- Maerk I, Grabmeier G, Kratzik C, et al. The role of inhibin in men with untreated prostate cancer. Eur Urol. 2004;3(suppl 2) Abstract 163.
-
- Kuratsukuri K, Sugimura K, Nakatani T, et al. Inhibition of prostate-specific membrane antigen (PSMA)-positive tumour growth by vaccination with either full length or the c-terminus of PSMA. Eur Urol. 2004;3(suppl 2) Abstract 357.
-
- Fullerton NE, Boyd M, Mairs RJ, et al. Targeted radiotherapy and gene therapy for prostate cancer: transfection of the noradrenaline transporter-gene under the control of telomerase promoters; in vitro and in vivo studies. Eur Urol. 2004;3(suppl 2) Abstract 361.
-
- Wolfram R, Dobrovits M, Djavan B, et al. Prostate cancer apoptosis in androgen dependent and independent cell cultures harvested from in vivo specimen. Eur Urol. 2004;3(suppl 2) Abstract 580.
-
- Kramer G, Steiner G, Groebl M, et al. The response to sublethal heat treatment of prostatic tumour cells and of prostatic tumour infiltrating T-cells. Eur Urol. 2004;3(suppl 2) Abstract 587. - PubMed
LinkOut - more resources
Full Text Sources